Dr. Kai Pinkernell is Senior Vice President Medical Affairs, Chief Medical Officer, at Medigene AG and responsible for clinical and GMP process development. Medigene AG is a stock listed (Frankfurt: MDG1, Prime Standard) biotechnology company with its headquarters in Martinsried, Munich. Medigene concentrates on the development of personalized immunotherapies with a focus on hematooncology
Previously, Dr. Pinkernell was the Global Head of Clinical Business at Miltenyi Biotec GmbH, leading clinical marketing, sales and development, worldwide. Also, Dr. Pinkernell has been with Cytori Therapeutics Inc., San Diego, USA, from 2005 to 2009, as Senior Director of Regenerative Cell Technology and Clinical Applications Director. He received his medical degree from the Westfaelische-Wilhems University in Muenster, Germany, and pursued a residency/fellowship in internal medicine/cardiology at the German Heart Center and Klinikum Rechts der Isar, Technical University, in Munich, Germany. He further received a Master of Business Administration from the Marshall School of Business at the University of Southern California, Los Angeles, USA.